First human tests begin for potential lung and tumor drug

NCT ID NCT05740475

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new drug called 9MW3811 for the first time in humans. The main goal was to check if it is safe and how well it is tolerated in 32 healthy adults aged 18 to 55. Researchers gave a single dose and monitored for side effects, measuring how the drug moves through the body. This early research is a necessary step before testing the drug in people with diseases like pulmonary fibrosis or tumors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PULMONARY FIBROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Scientia Clinical Research

    Randwick, New South Wales, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.